Clinical Trial

A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2024 (before its estimated October 7, 2024 completion). Its status may not reflect the trial's current state.
Summary
The efficacy and safety of IAP0971 single drug or combined with BCG intravesical instillation in the treatment of high-risk non muscle invasive bladder cancer with BCG treatment failure.
Trial Details
NCT Number NCT06255964
Lead Sponsor SUNHO（China）BioPharmaceutical CO., Ltd.
Conditions Bladder Cancer
Enrollment 236 participants
Start Date 2024-02-15
Primary Completion 2024-10-07 (estimated)
Study Completion 2026-12-07 (estimated)
Updated on ClinicalTrials.gov 2024-02-13